{"id":16219,"date":"2026-08-31T11:20:00","date_gmt":"2026-08-31T11:20:00","guid":{"rendered":"https:\/\/recomm.eu\/speaker\/ronjon-nag\/"},"modified":"2026-08-31T11:20:00","modified_gmt":"2026-08-31T11:20:00","slug":"ronjon-nag","status":"publish","type":"speaker","link":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/","title":{"rendered":"Ronjon Nag"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Prof. Ronjon Nag ist KI-Pionier, Unternehmer sowie Gr\u00fcnder und CEO von Agemica und Gr\u00fcnder und Pr\u00e4sident der R42 Group. Als Professor f\u00fcr Genetik an der Stanford School of Medicine besch\u00e4ftigt er sich seit vielen Jahren mit der Verbindung von K\u00fcnstlicher Intelligenz, Biotechnologie und Longevity.<\/p>

In seiner Keynote auf der re.comm 26 mit dem Titel \u201eAI, the Aging Vaccine, and the Century Ahead\u201c<\/strong> geht Ronjon Nag der Frage nach, wie K\u00fcnstliche Intelligenz die Entwicklung neuer Impfstoffplattformen beschleunigen und damit neue M\u00f6glichkeiten im Kampf gegen Krebs und altersbedingte Erkrankungen er\u00f6ffnen k\u00f6nnte.<\/p>

Dabei zeigt er verst\u00e4ndlich, wie moderne AI-Methoden in der Impfstoffentwicklung eingesetzt werden, welche wissenschaftlichen und klinischen Erkenntnisse bereits vorliegen und welche regulatorischen sowie technologischen H\u00fcrden noch \u00fcberwunden werden m\u00fcssen.<\/p>

Sein Vortrag richtet den Blick aber auch weit \u00fcber die Medizin hinaus: Eine deutlich l\u00e4ngere menschliche Gesundheitsspanne k\u00f6nnte Demografie, St\u00e4dte, Immobilien, Vorsorgesysteme, Kapitalm\u00e4rkte und Karrierewege grundlegend ver\u00e4ndern. Ronjon Nag zeigt damit, wie eng technologische Innovation, gesellschaftlicher Wandel und strategische Entscheidungen in Zukunft miteinander verbunden sein werden.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"featured_media":16220,"template":"","meta":{"_acf_changed":false},"categories":[94],"tags":[],"class_list":["post-16219","speaker","type-speaker","status-publish","has-post-thumbnail","hentry","category-re-comm-26"],"acf":[],"yoast_head":"\nRonjon Nag - re.comm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ronjon Nag - re.comm\" \/>\n<meta property=\"og:description\" content=\"Prof. Ronjon Nag is an AI pioneer, entrepreneur, and the founder and CEO of Agemica, as well as the founder and president of the R42 Group. As a professor of genetics at Stanford School of Medicine, he has spent many years exploring the intersection of artificial intelligence, biotechnology, and longevity. In his keynote address at re.comm 26, titled \u201cAI, the Aging Vaccine, and the Century Ahead,\u201d Ronjon Nag explores how artificial intelligence could accelerate the development of new vaccine platforms and thereby open up new possibilities in the fight against cancer and age-related diseases. In doing so, he clearly explains how modern AI methods are being used in vaccine development, what scientific and clinical findings are already available, and what regulatory and technological hurdles still need to be overcome. However, his presentation also looks far beyond the field of medicine: a significantly longer human lifespan could fundamentally transform demographics, cities, real estate, pension systems, capital markets, and career paths. Ronjon Nag thus demonstrates how closely technological innovation, social change, and strategic decisions will be intertwined in the future.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/\" \/>\n<meta property=\"og:site_name\" content=\"re.comm\" \/>\n<meta property=\"og:image\" content=\"https:\/\/recomm.eu\/wp-content\/uploads\/2026\/08\/Ronjon.png\" \/>\n\t<meta property=\"og:image:width\" content=\"908\" \/>\n\t<meta property=\"og:image:height\" content=\"1136\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/\",\"url\":\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/\",\"name\":\"Ronjon Nag - re.comm\",\"isPartOf\":{\"@id\":\"https:\/\/recomm.eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/recomm.eu\/wp-content\/uploads\/2026\/08\/Ronjon.png\",\"datePublished\":\"2026-08-31T11:20:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#primaryimage\",\"url\":\"https:\/\/recomm.eu\/wp-content\/uploads\/2026\/08\/Ronjon.png\",\"contentUrl\":\"https:\/\/recomm.eu\/wp-content\/uploads\/2026\/08\/Ronjon.png\",\"width\":908,\"height\":1136},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/recomm.eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Speaker:innen\",\"item\":\"https:\/\/recomm.eu\/speakerinnen\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ronjon Nag\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/recomm.eu\/#website\",\"url\":\"https:\/\/recomm.eu\/\",\"name\":\"RE.COMM\",\"description\":\"Real Estate Leaders Summit\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/recomm.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ronjon Nag - re.comm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/","og_locale":"en_US","og_type":"article","og_title":"Ronjon Nag - re.comm","og_description":"Prof. Ronjon Nag is an AI pioneer, entrepreneur, and the founder and CEO of Agemica, as well as the founder and president of the R42 Group. As a professor of genetics at Stanford School of Medicine, he has spent many years exploring the intersection of artificial intelligence, biotechnology, and longevity. In his keynote address at re.comm 26, titled \u201cAI, the Aging Vaccine, and the Century Ahead,\u201d Ronjon Nag explores how artificial intelligence could accelerate the development of new vaccine platforms and thereby open up new possibilities in the fight against cancer and age-related diseases. In doing so, he clearly explains how modern AI methods are being used in vaccine development, what scientific and clinical findings are already available, and what regulatory and technological hurdles still need to be overcome. However, his presentation also looks far beyond the field of medicine: a significantly longer human lifespan could fundamentally transform demographics, cities, real estate, pension systems, capital markets, and career paths. Ronjon Nag thus demonstrates how closely technological innovation, social change, and strategic decisions will be intertwined in the future.","og_url":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/","og_site_name":"re.comm","og_image":[{"width":908,"height":1136,"url":"https:\/\/recomm.eu\/wp-content\/uploads\/2026\/08\/Ronjon.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/","url":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/","name":"Ronjon Nag - re.comm","isPartOf":{"@id":"https:\/\/recomm.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#primaryimage"},"image":{"@id":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#primaryimage"},"thumbnailUrl":"https:\/\/recomm.eu\/wp-content\/uploads\/2026\/08\/Ronjon.png","datePublished":"2026-08-31T11:20:00+00:00","breadcrumb":{"@id":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#primaryimage","url":"https:\/\/recomm.eu\/wp-content\/uploads\/2026\/08\/Ronjon.png","contentUrl":"https:\/\/recomm.eu\/wp-content\/uploads\/2026\/08\/Ronjon.png","width":908,"height":1136},{"@type":"BreadcrumbList","@id":"https:\/\/recomm.eu\/en\/speaker\/ronjon-nag\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/recomm.eu\/"},{"@type":"ListItem","position":2,"name":"Speaker:innen","item":"https:\/\/recomm.eu\/speakerinnen\/"},{"@type":"ListItem","position":3,"name":"Ronjon Nag"}]},{"@type":"WebSite","@id":"https:\/\/recomm.eu\/#website","url":"https:\/\/recomm.eu\/","name":"RE.COMM","description":"Real Estate Leaders Summit","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/recomm.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/recomm.eu\/en\/wp-json\/wp\/v2\/speaker\/16219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/recomm.eu\/en\/wp-json\/wp\/v2\/speaker"}],"about":[{"href":"https:\/\/recomm.eu\/en\/wp-json\/wp\/v2\/types\/speaker"}],"version-history":[{"count":0,"href":"https:\/\/recomm.eu\/en\/wp-json\/wp\/v2\/speaker\/16219\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/recomm.eu\/en\/wp-json\/wp\/v2\/media\/16220"}],"wp:attachment":[{"href":"https:\/\/recomm.eu\/en\/wp-json\/wp\/v2\/media?parent=16219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/recomm.eu\/en\/wp-json\/wp\/v2\/categories?post=16219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/recomm.eu\/en\/wp-json\/wp\/v2\/tags?post=16219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}